back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-12 17:15 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
64,000 | |
| Filed 2022-10-21 12:02 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,013
+200 vol $5.07 each |
10,000 | |
| Filed 2022-10-21 12:01 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,551
+300 vol $5.17 each |
9,800 | |
| Filed 2022-10-21 12:01 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,876
+368 vol $5.10 each |
9,500 | |
| Filed 2022-10-21 12:01 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,536
+300 vol $5.12 each |
9,132 | |
| Filed 2022-10-21 12:00 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$516.00
+100 vol $5.16 each |
8,832 | |
| Filed 2022-10-21 12:00 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,577
+700 vol $5.11 each |
8,732 | |
| Filed 2022-10-21 12:00 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,006
+1,732 vol $5.20 each |
8,032 | |
| Filed 2022-10-21 11:59 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,626
+700 vol $5.18 each |
6,300 | |
| Filed 2022-10-21 11:59 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,344
+5,600 vol $5.24 each |
5,600 | |
| Filed 2022-10-21 11:59 Tx date 2019-11-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-08 16:26 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
34,000 | |
| Filed 2019-11-15 14:46 Tx date 2019-11-12 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+19,000 vol |
19,000 | |
| Filed 2019-11-15 14:40 Tx date 2019-11-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|